Result Summary for 208108/059
| Protocol ID: | 208108/059 |
| Clinical Study ID: | 208108/059 (Hib-059) |
| Official Title: | A post-marketing surveillance study of GlaxoSmithKline Biologicals’ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Haemophilus influenzae Type b Vaccine |
| Trade/Product Name: | Hiberix;Hiberix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
